tiprankstipranks
FibroBiologics, Inc. (FBLG)
NASDAQ:FBLG
US Market
Holding FBLG?
Track your performance easily

FibroBiologics, Inc. (FBLG) Financial Statements

49 Followers

FibroBiologics, Inc. Financial Overview

FibroBiologics, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.59; its P/E ratio is -3.80; FibroBiologics, Inc. is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Sep 23Dec 22
Income Statement-
Total Revenue----
Gross Profit----
EBIT$ -495.00K$ 903.00K--
EBITDA$ -352.00K$ 1.04M--
Net Income Common Stockholders$ -500.00K$ 898.00K--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.83M$ 5.97M$ 10.77M$ 2.27M
Total Assets$ 10.47M$ 8.91M$ 13.30M$ 4.82M
Total Debt$ 1.56M$ 1.84M$ 1.80M$ 7.52M
Net Debt$ -6.26M$ -4.14M$ -8.97M$ 5.26M
Total Liabilities$ 7.73M$ 11.30M$ 2.76M$ 8.82M
Stockholders Equity$ 2.74M$ -2.39M$ 10.54M$ -4.00M
Cash Flow-
Free Cash Flow$ -2.62M$ -2.01M--
Operating Cash Flow$ -2.61M$ -1.95M--
Investing Cash Flow$ -11.00K$ -66.00K--
Financing Cash Flow$ 4.47M$ -172.00K--
Currency in USD

FibroBiologics, Inc. Earnings and Revenue History

FibroBiologics, Inc. Debt to Assets

FibroBiologics, Inc. Cash Flow

FibroBiologics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis